SPOTLIGHT -
News
Article
Author(s):
Expiring on May 20, 2024, this CME discusses how to apply several novel treatment approaches in the treatment of patients with bipolar depression. Here are 5 key takeaways.
Fast Track Designation Granted to Liafensine for Treatment-Resistant Depression
Blue Light Blockers: A Behavior Therapy for Mania
Specter of Suicidality with Antiobesity Med Looms Despite Disparate Study Findings
Treating ‘Morally Objectionable’ Patients
Psychiatry’s Risky Gamble on Recreational Drugs: The Royal Road to the Unconscious or Down a Pharmacologic Garden Path
With MDMA on Hold, What’s Next for Psychedelics?